Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: A meta-analysis of randomized control trials

Clinical Respiratory Journal

Volumn 8, Issue 3, 2014, Pages 281-291

  Nie, Wencheng ^a   Liu, Yanru ^b   Ye, Jian ^c   Shi, Liuhong ^b   Shao, Fangchun ^b   Ying, Kejing ^b   Zhang, Ruifeng ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Fibrinolytic; Intrapleural; Meta analysis; Parapneumonic effusion; Pleural empyema

Indexed keywords

FIBRINOLYTIC AGENT; PLACEBO; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; DATA EXTRACTION; DRUG EFFICACY; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HOSPITALIZATION; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; PARAPNEUMONIC EFFUSION; PLEURA EFFUSION; PLEURA EMPYEMA; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SURGERY; TREATMENT DURATION; TREATMENT OUTCOME; COMPLICATION; EMPYEMA, PLEURAL; LENGTH OF STAY; PLEURAL EFFUSION; PNEUMONIA; PROCEDURES;

EMPYEMA, PLEURAL; FIBRINOLYTIC AGENTS; HUMANS; LENGTH OF STAY; PLEURAL EFFUSION; PNEUMONIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOLYTIC THERAPY;

EID: 84903820515     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12068     Document Type: Article

References (37)

1. Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med. 1980;69: 507-512.
2. Desrumaux A, Francois P, Pascal C, Cans C, Croize J, etal. [Epidemiology and clinical characteristics of childhood parapneumonic empyemas]. Arch Pediatr. 2007;14: 1298-1303.
3. Roxburgh CS, Youngson GG. Childhood empyema in North-East Scotland over the past 15 years. Scott Med J. 2007;52: 25-27.
4. Munoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis. 2008;46: 174-182.
5. Finley C, Clifton J, Fitzgerald JM, Yee J. Empyema: an increasing concern in Canada. Can Respir J. 2008;15: 85-89.
6. Ferguson AD, Prescott RJ, Selkon JB, Watson D, Swinburn CR. The clinical course and management of thoracic empyema. QJM. 1996;89: 285-289.
7. Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med. 1999;160: 1682-1687.
8. Maskell NA, Davies CW, Nunn AJ, etal. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352: 865-874.
9. Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, Saikku P. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax. 2001;56: 296-301.
10. Farjah F, Symons RG, Krishnadasan B, Wood DE, Flum DR. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg. 2007;133: 346-351.
11. Ben-Or S, Feins RH, Veeramachaneni NK, Haithcock BE. Effectiveness and risks associated with intrapleural alteplase by means of tube thoracostomy. Ann Thorac Surg. 2011;91: 860-863. Discussion 863-4.
12. Stefanutti G, Ghirardo V, Barbato A, Gamba P. Evaluation of a pediatric protocol of intrapleural urokinase for pleural empyema: a prospective study. Surgery. 2010;148: 589-594.
13. Zuckerman DA, Reed MF, Howington JA, Moulton JS. Efficacy of intrapleural tissue-type plasminogen activator in the treatment of loculated parapneumonic effusions. J Vasc Interv Radiol. 2009;20: 1066-1069.
14. Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2008; Apr 16;(2): CD002312.
15. Wang JN, Yao CT, Yeh CN, Liu CC, Wu MH, Chuang HY, Wu JM. Once-daily vs. twice-daily intrapleural urokinase treatment of complicated parapneumonic effusion in paediatric patients: a randomised, prospective study. Int J Clin Pract. 2006;60: 1225-1230.
16. Chen JP, Lue KH, Liu SC, Cheng SL, Sheu JN. Intrapleural urokinase treatment in children with complicated parapneumonic effusion. Acta Paediatr Taiwan. 2006;47: 61-66.
17. Misthos P, Sepsas E, Konstantinou M, Athanassiadi K, Skottis I, Lioulias A. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study. Eur J Cardiothorac Surg. 2005;28: 599-603.
18. Barthwal MS, Deoskar RB, Rajan KE, Chatterjee RS. Intrapleural streptokinase in complicated parapneumonic effusions and empyema. Indian J Chest Dis Allied Sci. 2004;46: 257-261.
19. Narayan Prasad A. Intrapleural fibrinolytic therapy in a neonate. Indian J Pediatr. 2011;78: 1154-1156.
20. Aydogan M, Aydogan A, Ozcan A, Tugay M, Gokalp AS, Arisoy ES. Intrapleural streptokinase treatment in children with empyema. Eur J Pediatr. 2008;167: 739-744.
21. Tokuda Y, Matsushima D, Stein GH, Miyagi S. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis. Chest. 2006;129: 783-790.
22. Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2004;(2)CD002312.
23. Krenke K, Peradzynska J, Lange J, Ruszczynski M, Kulus M, Szajewska H. Local treatment of empyema in children: a systematic review of randomized controlled trials. Acta Paediatr. 2010;99: 1449-1453.
24. Rahman NM, Maskell NA, West A, etal. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365: 518-526.
25. Thommi G, Shehan JC, Robison KL, Christensen M, Backemeyer LA, McLeay MT. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions. Respir Med. 2012;106: 716-723.
26. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17: 1-12.
27. Singh M, Mathew JL, Chandra S, Katariya S, Kumar L. Randomized controlled trial of intrapleural streptokinase in empyema thoracis in children. Acta Paediatr. 2004;93: 1443-1445.
28. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med. 2004;170: 49-53.
29. Tuncozgur B, Ustunsoy H, Sivrikoz MC, Dikensoy O, Topal M, Sanli M, Elbeyli L. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract. 2001;55: 658-660.
30. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med. 1999;159: 37-42.
31. Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax. 1997;52: 416-421.
32. Thomson AH, Hull J, Kumar MR, Wallis C, Balfour Lynn IM. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax. 2002;57: 343-347.
33. Kercher KW. Thoracoscopic decortication as first-Line therapy for pediatric parapneumonic empyema: a case series. Chest. 2000;118: 24-27.
34. Light RW. A new classification of parapneumonic effusions and empyema. Chest. 1995;108: 299-301.
35. Tillett WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of postpneumonic empyema. J Thorac Surg. 1951;21: 275-297.
36. Davies CW, Lok S, Davies RJ. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med. 1998;157: 328-330.
37. Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas NM. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med. 1997;155: 291-295.